Entera Historical Financial Ratios

ENTX Stock

USD 1.64 0.06 3.53%

Entera Bio is recently reporting on over 91 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 1.76 or Days Sales Outstanding of 349 will help investors to properly organize and evaluate Entera Bio financial condition quickly.

Quick Ratio Current Ratio

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entera Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

About Entera Financial Ratios Analysis

Entera BioFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Entera Bio investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Entera financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Entera Bio history.

Entera Bio Financial Ratios Chart

At this time, Entera Bio's Net Debt To EBITDA is fairly stable compared to the past year. Current Ratio is likely to rise to 10.83 in 2024, whereas Price To Sales Ratio is likely to drop 79.86 in 2024.

Price To Sales Ratio Days Sales Outstanding Ev To Sales Payables Turnover Pe Ratio Ev To Free Cash Flow

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Entera Bio stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Entera Bio sales, a figure that is much harder to manipulate than other Entera Bio multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.

Most ratios from Entera Bio's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Entera Bio current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entera Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.At this time, Entera Bio's Net Debt To EBITDA is fairly stable compared to the past year. Current Ratio is likely to rise to 10.83 in 2024, whereas Price To Sales Ratio is likely to drop 79.86 in 2024.

	2021	2022	2023	2024 (projected)
Graham Number	3.01	2.04	1.57	1.49
Receivables Turnover	3.12	0.54	0.49	0.47

Graham Number Receivables Turnover

Entera Bio fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio
Price To Sales Ratio		0.66	-0.03	0.65	-0.59	0.06	-0.68	0.66	0.89	0.07	0.0	-0.57	0.08	-0.82	0.74	0.54	0.19	0.65	-0.7	0.77	0.64	-0.64	-0.12	-0.57	0.66	0.51
Ptb Ratio	0.66		-0.52	0.92	-0.83	-0.47	-0.91	1.0	0.61	-0.47	-0.11	-0.74	-0.31	-0.64	0.53	0.3	0.57	0.95	-0.71	0.96	0.95	-0.89	-0.05	-0.92	0.95	0.7
Days Sales Outstanding	-0.03	-0.52		-0.4	0.15	0.06	0.51	-0.52	-0.27	0.05	0.02	0.56	0.01	0.21	-0.01	0.39	-0.21	-0.31	0.39	-0.42	-0.31	0.38	0.03	0.39	-0.34	-0.26
Book Value Per Share	0.65	0.92	-0.4		-0.8	-0.46	-0.74	0.92	0.57	-0.46	0.07	-0.62	-0.18	-0.59	0.49	0.33	0.38	0.84	-0.63	0.86	0.84	-0.81	-0.11	-0.91	0.83	0.69
Free Cash Flow Yield	-0.59	-0.83	0.15	-0.8		0.4	0.75	-0.83	-0.33	0.4	0.07	0.73	0.21	0.59	-0.63	-0.69	-0.3	-0.92	0.7	-0.82	-0.92	0.78	0.01	0.95	-0.89	-0.69
Operating Cash Flow Per Share	0.06	-0.47	0.06	-0.46	0.4		0.22	-0.47	0.11	1.0	0.1	-0.11	0.81	-0.25	-0.05	0.14	-0.78	-0.49	-0.21	-0.28	-0.49	0.36	0.04	0.46	-0.48	-0.36
Capex To Depreciation	-0.68	-0.91	0.51	-0.74	0.75	0.22		-0.91	-0.59	0.22	0.27	0.75	0.16	0.67	-0.45	-0.39	-0.5	-0.9	0.75	-0.95	-0.9	0.86	-0.09	0.82	-0.91	-0.57
Pb Ratio	0.66	1.0	-0.52	0.92	-0.83	-0.47	-0.91		0.61	-0.47	-0.11	-0.74	-0.31	-0.64	0.53	0.3	0.57	0.95	-0.71	0.96	0.95	-0.89	-0.05	-0.92	0.95	0.7
Ev To Sales	0.89	0.61	-0.27	0.57	-0.33	0.11	-0.59	0.61		0.12	0.02	-0.54	0.1	-0.79	0.66	0.18	0.23	0.48	-0.65	0.7	0.48	-0.56	-0.14	-0.41	0.52	0.4
Free Cash Flow Per Share	0.07	-0.47	0.05	-0.46	0.4	1.0	0.22	-0.47	0.12		0.1	-0.11	0.81	-0.26	-0.04	0.14	-0.78	-0.49	-0.21	-0.28	-0.49	0.36	0.03	0.46	-0.48	-0.36
Roic	0.0	-0.11	0.02	0.07	0.07	0.1	0.27	-0.11	0.02	0.1		0.04	-0.16	0.0	-0.12	-0.02	-0.18	-0.15	0.02	-0.12	-0.15	0.49	-0.93	0.11	-0.1	0.55
Inventory Turnover	-0.57	-0.74	0.56	-0.62	0.73	-0.11	0.75	-0.74	-0.54	-0.11	0.04		-0.19	0.78	-0.57	-0.43	0.01	-0.69	0.93	-0.77	-0.69	0.67	0.01	0.76	-0.69	-0.53
Net Income Per Share	0.08	-0.31	0.01	-0.18	0.21	0.81	0.16	-0.31	0.1	0.81	-0.16	-0.19		-0.25	0.06	0.17	-0.87	-0.39	-0.24	-0.21	-0.39	0.04	0.41	0.18	-0.42	-0.51
Days Of Inventory On Hand	-0.82	-0.64	0.21	-0.59	0.59	-0.25	0.67	-0.64	-0.79	-0.26	0.0	0.78	-0.25		-0.63	-0.62	0.0	-0.63	0.95	-0.79	-0.63	0.63	0.05	0.56	-0.64	-0.49
Payables Turnover	0.74	0.53	-0.01	0.49	-0.63	-0.05	-0.45	0.53	0.66	-0.04	-0.12	-0.57	0.06	-0.63		0.49	0.1	0.54	-0.58	0.57	0.54	-0.58	0.06	-0.56	0.53	0.35
Capex To Revenue	0.54	0.3	0.39	0.33	-0.69	0.14	-0.39	0.3	0.18	0.14	-0.02	-0.43	0.17	-0.62	0.49		-0.16	0.52	-0.6	0.47	0.52	-0.38	0.04	-0.47	0.48	0.38
Cash Per Share	0.19	0.57	-0.21	0.38	-0.3	-0.78	-0.5	0.57	0.23	-0.78	-0.18	0.01	-0.87	0.0	0.1	-0.16		0.59	0.02	0.5	0.59	-0.41	-0.11	-0.35	0.62	0.43
Pocfratio	0.65	0.95	-0.31	0.84	-0.92	-0.49	-0.9	0.95	0.48	-0.49	-0.15	-0.69	-0.39	-0.63	0.54	0.52	0.59		-0.7	0.95	1.0	-0.86	-0.03	-0.92	1.0	0.73
Interest Coverage	-0.7	-0.71	0.39	-0.63	0.7	-0.21	0.75	-0.71	-0.65	-0.21	0.02	0.93	-0.24	0.95	-0.58	-0.6	0.02	-0.7		-0.82	-0.7	0.67	0.03	0.69	-0.7	-0.54
Capex To Operating Cash Flow	0.77	0.96	-0.42	0.86	-0.82	-0.28	-0.95	0.96	0.7	-0.28	-0.12	-0.77	-0.21	-0.79	0.57	0.47	0.5	0.95	-0.82		0.95	-0.88	-0.04	-0.86	0.96	0.69
Pfcf Ratio	0.64	0.95	-0.31	0.84	-0.92	-0.49	-0.9	0.95	0.48	-0.49	-0.15	-0.69	-0.39	-0.63	0.54	0.52	0.59	1.0	-0.7	0.95		-0.85	-0.03	-0.92	1.0	0.73
Days Payables Outstanding	-0.64	-0.89	0.38	-0.81	0.78	0.36	0.86	-0.89	-0.56	0.36	0.49	0.67	0.04	0.63	-0.58	-0.38	-0.41	-0.86	0.67	-0.88	-0.85		-0.39	0.87	-0.83	-0.34
Income Quality	-0.12	-0.05	0.03	-0.11	0.01	0.04	-0.09	-0.05	-0.14	0.03	-0.93	0.01	0.41	0.05	0.06	0.04	-0.11	-0.03	0.03	-0.04	-0.03	-0.39		-0.04	-0.1	-0.69
Roe	-0.57	-0.92	0.39	-0.91	0.95	0.46	0.82	-0.92	-0.41	0.46	0.11	0.76	0.18	0.56	-0.56	-0.47	-0.35	-0.92	0.69	-0.86	-0.92	0.87	-0.04		-0.9	-0.66
Ev To Operating Cash Flow	0.66	0.95	-0.34	0.83	-0.89	-0.48	-0.91	0.95	0.52	-0.48	-0.1	-0.69	-0.42	-0.64	0.53	0.48	0.62	1.0	-0.7	0.96	1.0	-0.83	-0.1	-0.9		0.77
Pe Ratio	0.51	0.7	-0.26	0.69	-0.69	-0.36	-0.57	0.7	0.4	-0.36	0.55	-0.53	-0.51	-0.49	0.35	0.38	0.43	0.73	-0.54	0.69	0.73	-0.34	-0.69	-0.66	0.77

Click cells to compare fundamentals

Entera Bio Account Relationship Matchups

Entera Bio fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	110.14	54.49	129.07	156.94	141.25	79.86
Ptb Ratio	2.18	2.98	3.27	1.79	1.68	1.76
Book Value Per Share	1.27	0.98	0.36	0.86	0.41	0.38
Free Cash Flow Yield	(0.34)	(0.53)	(0.12)	(0.6)	(0.42)	(0.44)
Operating Cash Flow Per Share	(0.73)	(0.57)	(0.35)	(0.43)	(0.25)	(0.26)
Capex To Depreciation	0.17	0.24	0.32	0.73	0.3	0.29
Pb Ratio	2.18	2.98	3.27	1.79	1.68	1.76
Ev To Sales	47.07	32.14	86.0	65.76	59.18	42.32
Free Cash Flow Per Share	(0.74)	(0.57)	(0.35)	(0.44)	(0.25)	(0.27)
Roic	(0.94)	(1.57)	(0.53)	(1.11)	(0.83)	(0.87)
Net Income Per Share	(0.9)	(0.54)	(0.47)	(0.45)	(0.31)	(0.32)
Sales General And Administrative To Revenue	18.14	13.4	9.96	54.13	48.71	51.15
Research And Ddevelopement To Revenue	30.5	17.53	11.86	43.64	39.28	41.24
Capex To Revenue	0.17	0.15	0.0298	0.35	0.32	0.33
Cash Per Share	1.25	0.47	0.95	0.43	0.38	0.36
Pocfratio	(2.91)	(1.91)	(8.13)	(1.68)	(2.38)	(2.5)
Capex To Operating Cash Flow	(0.004485)	(0.005085)	(0.001876)	(0.00376)	(0.002326)	(0.002442)
Pfcf Ratio	(2.9)	(1.9)	(8.12)	(1.68)	(2.38)	(2.49)
Income Quality	0.95	0.83	1.04	0.74	0.96	1.12
Roe	(0.91)	(1.5)	(0.54)	(1.11)	(0.86)	(0.9)
Ev To Operating Cash Flow	(1.25)	(1.13)	(5.42)	(0.71)	(0.93)	(0.97)
Pe Ratio	(2.39)	(1.99)	(6.05)	(1.61)	(1.96)	(2.06)
Return On Tangible Assets	(0.68)	(1.03)	(0.47)	(1.0)	(0.76)	(0.79)
Ev To Free Cash Flow	(1.24)	(1.12)	(5.41)	(0.7)	(0.92)	(0.97)
Intangibles To Total Assets	0.0493	0.0488	0.0362	0.059	0.0678	0.0981
Net Debt To E B I T D A	1.31	0.73	2.02	0.95	1.21	1.27
Current Ratio	3.41	2.78	8.01	9.58	10.32	10.83
Tangible Book Value Per Share	0.93	0.33	0.86	0.41	0.36	0.38
Receivables Turnover	0.85	1.43	3.12	0.54	0.49	0.47
Graham Number	4.45	2.1	3.01	2.04	1.57	1.49
Shareholders Equity Per Share	1.27	0.98	0.36	0.86	0.41	0.38

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Entera Stock Analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity	Operating Cycle
Cash Conversion Cycle

Entera Historical Financial Ratios

About Entera Financial Ratios Analysis

Entera Bio Financial Ratios Chart

Price To Sales Ratio

Ev To Sales

Payables Turnover

Ev To Free Cash Flow

Entera Bio fundamentals Correlations

Entera Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Entera Bio fundamentals Accounts

Also Currently Popular

Additional Tools for Entera Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pfcf Ratio	+ 1.0	Pocfratio
Ev To Operating Cash Flow	+ 1.0	Pocfratio
Ev To Operating Cash Flow	+ 1.0	Pfcf Ratio
Capex To Operating Cash Flow	+ 0.96	Ptb Ratio

Capex To Operating Cash Flow	- 0.95	Capex To Depreciation
Income Quality	- 0.93	Roic
Roe	- 0.92	Pfcf Ratio
Roe	- 0.92	Pocfratio
Roe	- 0.92	Pb Ratio
Pfcf Ratio	- 0.92	Free Cash Flow Yield